Nonoperating Income (Expense) in USD of Rallybio Corp from Q2 2020 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Rallybio Corp quarterly/annual Nonoperating Income (Expense) history and change rate from Q2 2020 to Q3 2025.
- Rallybio Corp Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $22.9M, a 1755% increase year-over-year.
- Rallybio Corp Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $25.4M, a 366% increase year-over-year.
- Rallybio Corp annual Nonoperating Income (Expense) for 2024 was $4.96M, a 22.6% decline from 2023.
- Rallybio Corp annual Nonoperating Income (Expense) for 2023 was $6.41M, a 178% increase from 2022.
- Rallybio Corp annual Nonoperating Income (Expense) for 2022 was $2.31M, a 1546% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)